East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Tofacitinib Tablets, 5 mg and 10 mg. Aurobindo Pharma’s Tofacitinib Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Xeljanz Tablets, manufactured by PF Prism C.V. Tofacitinib Tablets are […] The post Aurobindo Receives FDA Approval for Tofacitinib Tablets, 5 mg and 10 mg appeared first on Aurobindo Pharma USA .